De Vos-Geelen, J., Venerito, M., Von-Werder, A., Jann, H., Rinke, A., Smith, D., . . . Benavent Viñuales, M. (2025). Streptozotocin plus 5-fluorouracil followed by everolimus or the reverse sequence in patients with advanced pancreatic neuroendocrine tumors (SEQTOR-GETNE phase III study): A randomized clinical trial.
Citación estilo ChicagoDe Vos-Geelen, J., et al. Streptozotocin Plus 5-fluorouracil Followed By Everolimus or the Reverse Sequence in Patients With Advanced Pancreatic Neuroendocrine Tumors (SEQTOR-GETNE Phase III Study): A Randomized Clinical Trial. 2025.
Cita MLADe Vos-Geelen, J., et al. Streptozotocin Plus 5-fluorouracil Followed By Everolimus or the Reverse Sequence in Patients With Advanced Pancreatic Neuroendocrine Tumors (SEQTOR-GETNE Phase III Study): A Randomized Clinical Trial. 2025.